Failure to Include Black Communities in Health Policy Public Engagement Perpetuates Health Disparities
The fact that the communities with the worst health outcomes are also the communities least likely to be meaningfully engaged ...
Do We Really Know What a Million COVID-19 Deaths Mean?
For most people, visualizing what a million of anything looks like is an impossible task. The human brain just isn’t ...
Tomorrow’s COVID Safety Guidelines Will be Different From Today’s
The constant back and forth of rules can be frustrating, but policy changes aren’t usually a sign of mistakes. Rather, ...
Why the Opioid Epidemic is Poorly Reported
Few medical crises as large as the opioid epidemic have been so poorly reported. We present the results from our ...
Lack of Research Over Long COVID
COVID-19 is now two years old. Along the way, it transitioned from an acute to a chronic condition. In the ...
Healthcare Venture Growth Rarely Becomes Profitable
Growth for successful healthcare startups is defined financially. In reality, growth should be defined by clinical improvements, which is less ...
The Human Genome Project Pieced Together Only 92% of the DNA – Now Scientists have Filled in the Remaining 8%
The first end-to-end human genome was officially published on Mar. 31, 2022.
How Does the COVID-19 Prevention Drug Evusheld Work?
Evusheld is the first FDA-authorized drug to prevent COVID-19 in high-risk people who aren’t adequately protected by vaccination alone.
Alopecia is No Laughing Matter for Millions of Black American Women
Alopecia is a medical word that refers to hair loss generally. And there are descriptors added which can refer to ...
What is the 411 on the New 988 Hotline?
The 988 Lifeline will connect callers with specialists trained to assist with mental health crises, including psychotic symptoms and substance ...
Even after Lockdowns Eased, Pandemic Depression Persisted Across Social Classes
One year into the COVID-19 pandemic, we found that more than 1 in 5 U.S. adults reported probable depression in ...
Mapping Shifts in Healthcare Labor Markets
For how much we discuss staffing shortages and limited access to care, we have a poor sense of the labor ...
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more